Related Experiment Video
Updated: May 22, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt
Quan-Jiang Zhang1, William L Holland, Lloyd Wilson
1College of Health, University of Utah, Salt Lake City, Utah, USA.
Abstract:
Vascular dysfunction that accompanies obesity and insulin resistance may be mediated by lipid metabolites. We sought to determine if vascular ceramide leads to arterial dysfunction and to elucidate the underlying mechanisms. Pharmacological inhibition of de novo ceramide synthesis, using the Ser palmitoyl transferase inhibitor myriocin, and heterozygous deletion of dihydroceramide desaturase prevented vascular dysfunction and hypertension in mice after high-fat feeding. These findings were recapitulated in isolated arteries in vitro, confirming that ceramide impairs endothelium-dependent vasorelaxation in a tissue-autonomous manner. Studies in endothelial cells reveal that de novo ceramide biosynthesis induced protein phosphatase 2A (PP2A) association directly with the endothelial nitric oxide synthase (eNOS)/Akt/Hsp90 complex that was concurrent with decreased basal and agonist-stimulated eNOS phosphorylation. PP2A attenuates eNOS phosphorylation by preventing phosphorylation of the pool of Akt that colocalizes with eNOS and by dephosphorylating eNOS. Ceramide decreased the association between PP2A and the predominantly cytosolic inhibitor 2 of PP2A. We conclude that ceramide mediates obesity-related vascular dysfunction by a mechanism that involves PP2A-mediated disruption of the eNOS/Akt/Hsp90 signaling complex. These results provide important insight into a pathway that represents a novel target for reversing obesity-related vascular dysfunction.
Insights
Vascular dysfunction in obesity is linked to ceramides. Inhibiting ceramide synthesis reversed arterial dysfunction and hypertension in mice by preserving endothelial nitric oxide synthase signaling.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Metabolic Disease Research
Background:
- Obesity and insulin resistance are associated with vascular dysfunction, potentially mediated by lipid metabolites.
- Ceramides, a class of lipid metabolites, are implicated in cellular dysfunction.
Purpose of the Study:
- To investigate if vascular ceramides contribute to arterial dysfunction.
- To elucidate the molecular mechanisms by which ceramides impair vascular function.
Main Methods:
- Pharmacological inhibition of de novo ceramide synthesis using myriocin.
- Genetic deletion of dihydroceramide desaturase in mice.
- In vitro studies using isolated arteries and endothelial cells.
Main Results:
- Inhibition of ceramide synthesis prevented vascular dysfunction and hypertension in high-fat-fed mice.
- Ceramide impaired endothelium-dependent vasorelaxation in isolated arteries.
- Ceramide disrupted the endothelial nitric oxide synthase (eNOS)/Akt/Hsp90 complex via protein phosphatase 2A (PP2A) in endothelial cells, reducing eNOS phosphorylation.
Conclusions:
- Ceramide mediates obesity-related vascular dysfunction through PP2A-dependent disruption of the eNOS/Akt/Hsp90 signaling complex.
- Targeting ceramide synthesis offers a novel therapeutic strategy for reversing obesity-associated vascular dysfunction.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Lipid Catabolism
Chronic Pancreatitis II: Pathophysiology
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
PI3K/mTOR/AKT Signaling Pathway
Acute Pancreatitis II: Pathophysiology
